Bowens Disease

Also known as: Bowen Disease / Cutaneous Squamous Cell Carcinoma in Situ (CSCCis) / Cutaneous Squamous Cell Carcinoma in Situ / Squamous Cell Carcinoma in Situ / Bowen's Disease / Squamous cell carcinoma in situ (morphologic abnormality) / Squamous intraepithelial neoplasia, grade III (morphologic abnormality) / Intra-epidermal carcinoma / Intraepithelial squamous cell carcinoma (disorder) / Intraepidermal carcinoma / Bowen's disease (morphologic abnormality) / Squamous cell carcinoma in situ of skin (disorder) / Planocellular carcinoma / Squamous cell carcinoma (morphologic abnormality) / Squamous cell carcinoma (disorder) / Epidermoid carcinoma / Carcinoma, Squamous Cell / Squamous cell carcinoma / Carcinoma epidermoid / Carcinoma squamous

DrugDrug NameDrug Description
DB00855Aminolevulinic acidA porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma.
DrugDrug NamePhaseStatusCount
DB00281Lidocaine1Completed1
DB00992Methyl aminolevulinate1Completed1
DB00750Prilocaine1Completed1
DB18404Cotsiranib1 / 2Completed1
DB18404Cotsiranib2Completed1
DB02300Calcipotriol2 / 3Recruiting1
DB00544Fluorouracil2 / 3Recruiting1
DB00724Imiquimod2 / 3Unknown Status1
DB00544Fluorouracil4Recruiting1
DB00992Methyl aminolevulinate4Recruiting1
DB00668EpinephrineNot AvailableCompleted1
DB00281LidocaineNot AvailableCompleted1
DB00992Methyl aminolevulinateNot AvailableCompleted1
DB00992Methyl aminolevulinateNot AvailableNo Longer Available1